Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Airway

No description
by

Sammy Block

on 18 June 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Airway

Stroke Victims
~ 43-54% stroke patients with dysphagia experience aspiration
- 37% pneumonia
- 3.8% die of pneumonia

- "Patients with dysphagia are more likely to die in the first 90 days post-stroke, which is why it is so important that people are screened and treated early for this condition."

Airway
Sammy Block
Julie DeJaco
Tess Likens
Joshua Powell
Tyler Standifer
Treatment Options
- High and low dysphagia
- Differences between high and low dysphagia
- Treatment options


Other Diseases Involving Dysphagia

- Brain Tumor
- 14.5% of 117 patients

- Institutionalized Dementia
- 45%

- Gastroesophageal Reflux Disease (GERD)
- 5-7% of the population

- Choking Victims
- 8,000-10,000 had progressive nerve and muscle problems
General Statistics
- 61% - Acute Trauma centers
- 41% - Rehab settings
- 30-75% - Nursing homes
- 25-30% - Hospitals



Top 5 Competitors
- Vitalstim
- UC Davis Piercing Prototype
- iSwallow- The Senior Edition
- Madison Oral Strengthening Therapeutic (MOST®) Device
- Wallflex Fully Covered Esophageal Stent
VitalStim
UC Davis Piercing
Prototype
iSwallow- The Senior Edition
Madison Oral Strengthening
Therapeutic (MOST®) Device
Wallflex Fully Covered
Esophageal Stent
Conclusion
- Attractive Market

- Limited Competitors

- High chance of success

Demographics
Agenda
- Treatment Options
- Demographics
- Market Size
- Competitors
- Conclusion
- 5-15% of total population
- Adults: 7-10%
- Children: Neurological or Anatomical abnormalities
Full transcript